z-logo
open-access-imgOpen Access
Treatment with lamivudine, zidovudine, or both in hiv-positive patients with 200 to 500 cd4+ cells per cubic millimeter
Author(s) -
Joseph J. Eron,
Sharon L. Benoit,
Joseph G. Jemsek,
Rodger D. MacArthur,
Jorge Santana,
Joseph Quinn,
Daniel R. Kuritzkes,
Mary Ann Fallon,
Marc Rubin
Publication year - 1995
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/d9hy-p653
Subject(s) - zidovudine , lamivudine , human immunodeficiency virus (hiv) , virology , medicine , virus , viral disease , hepatitis b virus

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom